Arnulf Hinrich Hoelscher

Arnulf Hoelscher is a gastric and esophageal surgeon who contributed to the AIO-STO-0415 FLOT4 trial demonstrating superiority of FLOT (docetaxel, oxaliplatin, leucovorin, 5-FU) over the ECF/ECX regimen for perioperative treatment of gastric and GEJ cancers. His expertise in gastric and esophageal surgery including D2 gastrectomy and esophagectomy provides the surgical backbone for perioperative chemotherapy trials. He has contributed to German S3 guidelines for gastric cancer management. Hoelscher's work integrates surgical quality and perioperative systemic therapy optimization for resectable gastric cancer.